Advisortrust Partners’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$681K Buy
14,143
+979
+7% +$50K 0.21% 86
2026
Q2
$690K Buy
13,164
+723
+6% +$38.2K 0.24% 74
2026
Q1
$687K Sell
12,441
-2,358
-16% -$128K 0.29% 54
2025
Q4
$726K Buy
+14,799
New +$690K 0.32% 48

Other funds holding GSK

Advisortrust Partners's GSK Position: Q3 2026 in Review

Advisortrust Partners increased its GSK (GSK) stake by 7.4% in Q3 2026, buying an estimated $50K and bringing the position to 14,143 shares worth $681K. The position accounts for 0.21% of the portfolio, ranked #86.

Advisortrust Partners first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $726K in Q4 2025. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Advisortrust Partners held 14,143 shares of GSK worth $681K as of Q3 2026.
  • Advisortrust Partners bought 979 GSK shares in Q3 2026, an estimated $50K.
  • GSK made up 0.21% of Advisortrust Partners's portfolio in Q3 2026, its #86 holding.
  • Advisortrust Partners first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • Advisortrust Partners's GSK position peaked at $726K in Q4 2025.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.